S. Huskey

发表

THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL

Bonnie Wang, R. Sanchez, R. Franklin, 2004, Drug Metabolism and Disposition.

N-Glucuronidation of Xenobiotics Symposium SPECIES DIFFERENCES IN N-GLUCURONIDATION

S. Huskey, S. H. Chiu, 1998 .

Derivatization of ethinylestradiol with dansyl chloride to enhance electrospray ionization: application in trace analysis of ethinylestradiol in rhesus monkey plasma.

R. Franklin, D. C. Evans, S. Huskey, 2002, Analytical chemistry.

Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression.

Yudong D. He, R. Ulrich, R. Evers, 2004, Molecular pharmacology.

Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.

R. Miller, D. Dean, S. Huskey, 1995, Drug metabolism and disposition: the biological fate of chemicals.

Application of LC-NMR for the study of the volatile metabolite of MK-0869, a substance P receptor antagonist.

S. Huskey, B. Zhu, M. Elipe, 2003, Journal of pharmaceutical and biomedical analysis.

Transport of Ethinylestradiol Glucuronide and Ethinylestradiol Sulfate by the Multidrug Resistance Proteins MRP1, MRP2, and MRP3

X. Chu, R. Evers, B. Sarkadi, 2004, Journal of Pharmacology and Experimental Therapeutics.

The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 alpha-ethinylestradiol.

Bonnie Wang, R. Sanchez, R. Franklin, 2004, Drug metabolism and disposition: the biological fate of chemicals.

Species differences in N-glucuronidation.

S. Huskey, S H Chiu, S W Huskey, 1998, Drug metabolism and disposition: the biological fate of chemicals.

N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes.

R. Miller, G. Doss, S. Huskey, 1994, Drug metabolism and disposition: the biological fate of chemicals.

CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT

P. Lu, R. Sanchez, D. C. Evans, 2004, Drug Metabolism and Disposition.

Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators*

D. Moller, D. E. Biazzo-Ashnault, V. Ding, 2000, The Journal of Biological Chemistry.

Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs.

J. Metzger, M. Maccoss, D. Macintyre, 2000, Journal of medicinal chemistry.

Substance P receptor antagonist I: conversion of phosphoramidate prodrug after i.v. administration to rats and dogs.

S. Huskey, W. Feeney, S. H. Chiu, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant

T. Bradstreet, S. Swan, A. Bergman, 2005, Clinical pharmacokinetics.

Site-directed mutagenesis of glutathione S-transferase YaYa. Important roles of tyrosine 9 and aspartic acid 101 in catalysis.

A. Y. Lu, C. B. Pickett, S. Huskey, 1992, The Journal of biological chemistry.